West Pharmaceutical Services Inc. buy Citigroup Inc.
Start price
08.01.25
/
50%
€326.40
Target price
08.01.26
€388.28
Performance (%)
-28.37%
End price
09.01.26
€233.80
Summary
This prediction ended on 09.01.26 with a price of €233.80. The price of West Pharmaceutical Services Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.37%. A total of €0.20 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| West Pharmaceutical Services Inc. | 0.190% | 0.190% | 11.346% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
Comments by Citigroup_Inc_ for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten